Safety and Efficacy of Secukinumab in a Child with CARD14-Associated Papulosquamous Eruption: A Case Report and Review of Literature-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and Efficacy of Secukinumab in a Child with CARD14-Associated Papulosquamous Eruption: A Case Report and Review of Literature

Published:2024-09-12 Issue: Volume: Page:
ISSN:2229-5178
Container-title:Indian Dermatology Online Journal
language:en
Short-container-title:

Author:

Chiramel Minu J.¹,Sathishkumar Dharshini¹,Jayakrishna A¹

Affiliation:

1. Department of Dermatology, Venereology and Leprosy, Christian Medical College, Vellore, Tamil Nadu, India

Publisher

Medknow

Reference10 articles.

1. Two cases of CARD14-associated papulosquamous eruption from India;Chiramel;Pediatr Dermatol,2020

2. CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris;Craiglow;J Am Acad Dermatol,2018

3. Clinical and genetic heterogeneity of CARD14 mutations in psoriatic skin disease;Israel;Front Immunol,2018

4. CARD14 missense variant underlying CARD14-associated papulosquamous eruption with beneficial response to secukinumab;Dai;JID Innov,2023

5. CARD14-associated papulosquamous eruption flare-up after SARS-CoV-2 infection in a child: Secukinumab a safe and effective treatment;Chessa;Int J Dermatol,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP